Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1954 1
1958 1
1960 1
1966 1
1967 2
1968 2
1969 1
1971 2
1972 1
1973 1
1974 1
1975 1
1976 4
1977 2
1978 2
1979 3
1980 2
1981 1
1982 6
1983 9
1984 3
1985 8
1986 8
1987 8
1988 8
1989 11
1990 10
1991 12
1992 8
1993 8
1994 3
1995 9
1996 6
1997 7
1998 8
1999 6
2000 7
2001 8
2002 8
2003 8
2004 6
2005 11
2006 8
2007 10
2008 13
2009 7
2010 13
2011 10
2012 8
2013 11
2014 9
2015 7
2016 18
2017 19
2018 22
2019 19
2020 24
2021 15
2022 14
2023 10
2024 10
2025 5

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

448 results

Results by year

Filters applied: . Clear all
Page 1
Refining strategies for biological and targeted synthetic DMARD initiation in rheumatoid arthritis - Authors' reply.
Russell MD, Gibson M, Zuckerman B, Kumar K, Dubey S, Adas MA, Alveyn E, Patel S, Yang Z, Bechman K, Price E, Gallagher S, Cope AP, Norton S, Galloway JB. Russell MD, et al. Among authors: zuckerman b. Lancet Rheumatol. 2025 Mar;7(3):e159-e160. doi: 10.1016/S2665-9913(25)00029-3. Epub 2025 Feb 5. Lancet Rheumatol. 2025. PMID: 39922215 No abstract available.
Oral condylomata lata.
Moezinia CJ, Zuckerman BP, Abdul-Hamid A. Moezinia CJ, et al. Among authors: zuckerman bp. Cleve Clin J Med. 2024 Dec 2;91(12):725-726. doi: 10.3949/ccjm.91a.24045. Cleve Clin J Med. 2024. PMID: 39622592 Free article. No abstract available.
Temporal and regional variation in the use of biologic and targeted synthetic DMARDs for rheumatoid arthritis: a nationwide cohort study.
Russell MD, Yang Z, Dooley N, Gibson M, Zuckerman B, Adas MA, Alveyn E, Patel S, Bechman K, Price E, Gallagher S, Coalwood C, Cope AP, Norton S, Galloway JB. Russell MD, et al. Among authors: zuckerman b. Rheumatology (Oxford). 2024 Nov 1:keae607. doi: 10.1093/rheumatology/keae607. Online ahead of print. Rheumatology (Oxford). 2024. PMID: 39485485
Factors associated with biological and targeted synthetic disease-modifying antirheumatic drug initiation for rheumatoid arthritis in underserved patient groups in England and Wales, UK: a national cohort study.
Russell MD, Gibson M, Zuckerman B, Kumar K, Dubey S, Adas MA, Alveyn E, Patel S, Yang Z, Bechman K, Price E, Gallagher S, Cope AP, Norton S, Galloway JB. Russell MD, et al. Among authors: zuckerman b. Lancet Rheumatol. 2025 Jan;7(1):e44-e54. doi: 10.1016/S2665-9913(24)00221-2. Epub 2024 Oct 16. Lancet Rheumatol. 2025. PMID: 39423845 Free article.
448 results